Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aclarion Inc. Warrant (ACONW:NASDAQ), powered by AI.
Aclarion Inc. Warrant is currently trading at $0.03. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Aclarion Inc. Warrant on Alpha Lenz.
View Aclarion Inc. Warrant's valuation metrics on Alpha Lenz.
“Aclarion Inc. Warrant's ROE is -104.8%. Explore profitability and growth together.”
Ask for details →Aclarion Inc. Warrant represents a financial derivative issued by Aclarion Inc., which grants the holder the right, but not the obligation, to purchase shares of the company's stock at a specified price before the expiration date. This warrant serves as a tool for investors looking to gain potential upside exposure to Aclarion Inc.'s equity performance without the need to commit substantial capital upfront. Warrants are often issued along with an equity offering, providing additional incentive for investors by adding a leveraged component to their portfolio strategies. Aclarion Inc., as a company, operates within the medical technology sector, focusing on solutions that enhance diagnostic accuracy and treatment outcomes. The warrant plays a significant role in capital markets by enabling flexibility in investment strategies and allowing investors to leverage their positions in anticipation of corporate growth or favorable market conditions. The presence of such warrants in the financial market highlights the dynamic nature of equity financing tools and their role in accommodating diverse investor needs.
“Aclarion Inc. Warrant's ROE is -104.8%. Explore profitability and growth together.”
Ask for details →Aclarion Inc. Warrant (ticker: ACONW) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 5 employees.
The current price is $0.027 with a P/E ratio of -x and P/B of -x.
ROE is -104.80% and operating margin is -9312.55%. Annual revenue is $75,730.